HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Wilke Selected Research

Interferons

6/2012Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Wilke Research Topics

Disease

1Neck Pain (Cervicalgia)
10/2014
1Disease Progression
06/2012
1Renal Cell Carcinoma (Grawitz Tumor)
06/2012
1Atopic Dermatitis (Atopic Eczema)
04/2010
1Hemorrhage
08/2006
1Gastric Polyposis
08/2006
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2001

Drug/Important Bio-Agent (IBA)

1InterferonsIBA
06/2012
1EtoricoxibIBA
06/2012
1Capecitabine (Xeloda)FDA Link
06/2012
1Pioglitazone (Actos)FDA Link
06/2012
1Biomarkers (Surrogate Marker)IBA
04/2010

Therapy/Procedure

2Therapeutics
06/2012 - 06/2001
1Lasers (Laser)
10/2014
1Drug Therapy (Chemotherapy)
06/2012
1Gastrectomy
08/2006